IL161145A0 - Granulate or powder for producing coating or binding agents for medicaments - Google Patents
Granulate or powder for producing coating or binding agents for medicamentsInfo
- Publication number
- IL161145A0 IL161145A0 IL16114503A IL16114503A IL161145A0 IL 161145 A0 IL161145 A0 IL 161145A0 IL 16114503 A IL16114503 A IL 16114503A IL 16114503 A IL16114503 A IL 16114503A IL 161145 A0 IL161145 A0 IL 161145A0
- Authority
- IL
- Israel
- Prior art keywords
- sub
- powders
- mixed
- granulate
- medicaments
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title abstract 3
- 239000000843 powder Substances 0.000 title abstract 3
- 239000011230 binding agent Substances 0.000 title abstract 2
- 239000011248 coating agent Substances 0.000 title abstract 2
- 238000000576 coating method Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000155 melt Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000001302 tertiary amino group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10239999A DE10239999A1 (de) | 2002-08-27 | 2002-08-27 | Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen |
| PCT/EP2003/007319 WO2004019918A1 (de) | 2002-08-27 | 2003-07-08 | Granulat oder pulver zur herstellung von überzugs- und bindemitteln für arzneiformen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL161145A0 true IL161145A0 (en) | 2004-08-31 |
Family
ID=31197526
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16114503A IL161145A0 (en) | 2002-08-27 | 2003-07-08 | Granulate or powder for producing coating or binding agents for medicaments |
| IL161145A IL161145A (en) | 2002-08-27 | 2004-03-29 | Process for preparation of granulate or powder for producing coating or binding agents for medicaments and granulate or powder obtained by said process |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL161145A IL161145A (en) | 2002-08-27 | 2004-03-29 | Process for preparation of granulate or powder for producing coating or binding agents for medicaments and granulate or powder obtained by said process |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7175857B2 (enExample) |
| EP (1) | EP1432409B1 (enExample) |
| JP (1) | JP4571861B2 (enExample) |
| KR (1) | KR100942667B1 (enExample) |
| AT (1) | ATE408401T1 (enExample) |
| AU (1) | AU2003266232A1 (enExample) |
| BR (1) | BRPI0306143B8 (enExample) |
| CA (1) | CA2464502C (enExample) |
| DE (2) | DE10239999A1 (enExample) |
| ES (1) | ES2314275T3 (enExample) |
| IL (2) | IL161145A0 (enExample) |
| IN (1) | IN2004CH00875A (enExample) |
| MX (1) | MX250472B (enExample) |
| PL (1) | PL206233B1 (enExample) |
| SI (1) | SI1432409T1 (enExample) |
| WO (1) | WO2004019918A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10208344A1 (de) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Schmelzextrusion von Wirkstoffsalzen |
| DE10260920A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen |
| DE10260919A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| DE10260921A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln |
| DE10304403A1 (de) * | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
| DE102004029573A1 (de) * | 2004-06-18 | 2005-12-29 | Gambro Lundia Ab | MIF-Adsorbent |
| JP4895819B2 (ja) * | 2004-10-29 | 2012-03-14 | 大鵬薬品工業株式会社 | プロピベリン含有経口粉粒状製剤及びその製造法 |
| EP1681049A1 (fr) * | 2005-01-12 | 2006-07-19 | Physica Pharma | Composition pharmaceutique et forme galénique correspondante à délitement rapide en bouche, et procédé de fabrication de cette composition |
| JP2008540437A (ja) * | 2005-05-03 | 2008-11-20 | ミユーチユアル・フアーマシユーチカルズ・カンパニー・インコーポレーテツド | キニーネを含有する制御放出調合剤 |
| DE102005042039A1 (de) * | 2005-09-02 | 2007-03-08 | Basf Ag | Wässrige Polyvinylacetatdispersionen mit hoher Scherstabilität |
| DK2046300T3 (da) * | 2006-08-04 | 2010-07-26 | Ethypharm Sa | Oralt desintegrerende multilagstablet |
| WO2009016258A1 (de) | 2007-08-02 | 2009-02-05 | Basf Se | Wässrige polymerdispersion auf basis von n, n-diethylaminoethylmethacrylat, deren herstellung und verwendung |
| WO2010030735A2 (en) * | 2008-09-11 | 2010-03-18 | Aethos Pharmaceuticals, Inc. | Stabilized coating for pharmaceutical formulations |
| WO2011051155A2 (en) | 2009-10-28 | 2011-05-05 | Basf Se | Stable protective coatings for pharmaceutical dosage forms |
| US20110150986A1 (en) * | 2009-12-18 | 2011-06-23 | Kristin Arnold | Quinine formulations, method of making, and metho of use thereof |
| WO2011110347A2 (en) * | 2010-03-10 | 2011-09-15 | Giuliani International Limited | Compositions for colon lavage and methods of making and using same |
| CA2799110A1 (en) * | 2010-05-10 | 2011-11-17 | Evonik Roehm Gmbh | Pharmaceutical dosage form comprising one or more antiretroviral active ingredients |
| CN103189052A (zh) | 2010-09-07 | 2013-07-03 | 巴斯夫欧洲公司 | 基于含氨基聚合物的共聚物作为基质粘合剂在制备含活性成分的颗粒和给药形式中的用途 |
| JP6012604B2 (ja) | 2010-09-27 | 2016-10-25 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 酸性有効成分のための保護コーティング |
| US9795576B2 (en) | 2010-09-27 | 2017-10-24 | Basf Se | Protective coatings for acidic active ingredients |
| CN103347931B (zh) | 2011-02-28 | 2016-02-17 | 巴斯夫欧洲公司 | 制备用于药物剂型的稳定保护性衣层的粉末包衣剂 |
| US8962064B2 (en) | 2011-02-28 | 2015-02-24 | Basf Se | Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| JP5937113B2 (ja) | 2011-02-28 | 2016-06-22 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 医薬剤形用の安定した保護被覆のための粉末被覆剤の製造 |
| US8865250B2 (en) | 2011-02-28 | 2014-10-21 | Basf Se | Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| US9044734B2 (en) | 2011-09-23 | 2015-06-02 | Basf Se | Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion |
| US20130236505A1 (en) | 2012-03-09 | 2013-09-12 | Basf Se | Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment |
| EP2636403A1 (de) * | 2012-03-09 | 2013-09-11 | Basf Se | Herstellung von pharmazeutischen protektiven Überzügen mit guter Resistenz im neutralen Milieu |
| US10668156B2 (en) | 2012-06-22 | 2020-06-02 | Basf Se | Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers |
| EP2863953A1 (de) | 2012-06-22 | 2015-04-29 | Basf Se | Wirkstoffhaltige festen dispersionen auf basis von diethylaminoethylmethacrylat-copolymeren |
| US20150290136A1 (en) * | 2012-11-22 | 2015-10-15 | Evonik Roehm Gmbh | Process for preparing a granulated product from a powder composition |
| FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
| GR1008992B (el) * | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
| EP3569225A1 (en) * | 2018-05-18 | 2019-11-20 | Pharmaceutical Oriented Services Ltd | Solid dispersion containing ritonavir |
| JP7058763B2 (ja) * | 2018-12-27 | 2022-04-22 | 興和株式会社 | 医薬品 |
| EP4255495A4 (en) | 2020-12-03 | 2025-10-08 | Battelle Memorial Institute | COMPOSITIONS OF POLYMERIC NANOPARTICLES AND DNA NANOSTRUCTURES AND METHODS FOR NON-VIRAL DELIVERY |
| WO2022216977A1 (en) | 2021-04-07 | 2022-10-13 | Batelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3581428D1 (de) * | 1984-06-13 | 1991-02-28 | Roehm Gmbh | Verfahren zum ueberziehen von arzneiformen. |
| DE3920082A1 (de) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung |
| DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Röhm GmbH, 64293 Darmstadt | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
| DE19918435A1 (de) * | 1998-07-23 | 2000-01-27 | Roehm Gmbh | Überzugs- und Bindemittel für orale oder dermale Arzneiformen |
| DE19958007A1 (de) * | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen |
| AU6345600A (en) * | 2000-07-14 | 2002-01-30 | Immunivest Corp | Increased separation efficiency via controlled aggregation of magnetic nanoparticles |
| CA2403831C (en) * | 2001-02-27 | 2009-11-24 | Rohm Gmbh & Co. Kg | Coating and binding agent for pharmaceutical formulations having improved storage stability |
| DE10208344A1 (de) * | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Schmelzextrusion von Wirkstoffsalzen |
-
2002
- 2002-08-27 DE DE10239999A patent/DE10239999A1/de not_active Withdrawn
-
2003
- 2003-07-08 EP EP03790791A patent/EP1432409B1/de not_active Expired - Lifetime
- 2003-07-08 ES ES03790791T patent/ES2314275T3/es not_active Expired - Lifetime
- 2003-07-08 MX MXPA04003970 patent/MX250472B/es active IP Right Grant
- 2003-07-08 AU AU2003266232A patent/AU2003266232A1/en not_active Abandoned
- 2003-07-08 JP JP2004531794A patent/JP4571861B2/ja not_active Expired - Lifetime
- 2003-07-08 DE DE50310506T patent/DE50310506D1/de not_active Expired - Lifetime
- 2003-07-08 IL IL16114503A patent/IL161145A0/xx unknown
- 2003-07-08 BR BRPI0306143A patent/BRPI0306143B8/pt active IP Right Grant
- 2003-07-08 CA CA2464502A patent/CA2464502C/en not_active Expired - Lifetime
- 2003-07-08 WO PCT/EP2003/007319 patent/WO2004019918A1/de not_active Ceased
- 2003-07-08 SI SI200331454T patent/SI1432409T1/sl unknown
- 2003-07-08 PL PL368186A patent/PL206233B1/pl unknown
- 2003-07-08 US US10/489,856 patent/US7175857B2/en not_active Expired - Lifetime
- 2003-07-08 AT AT03790791T patent/ATE408401T1/de active
-
2004
- 2004-03-29 IL IL161145A patent/IL161145A/en active IP Right Grant
- 2004-04-26 IN IN875CH2004 patent/IN2004CH00875A/en unknown
- 2004-04-27 KR KR20047006270A patent/KR100942667B1/ko not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL161145A (en) | 2010-11-30 |
| EP1432409B1 (de) | 2008-09-17 |
| WO2004019918A1 (de) | 2004-03-11 |
| MXPA04003970A (es) | 2004-06-22 |
| KR20050034620A (ko) | 2005-04-14 |
| BRPI0306143B8 (pt) | 2021-05-25 |
| US20040249035A1 (en) | 2004-12-09 |
| JP4571861B2 (ja) | 2010-10-27 |
| CA2464502A1 (en) | 2004-03-11 |
| KR100942667B1 (ko) | 2010-02-17 |
| IN2004CH00875A (enExample) | 2006-01-13 |
| CA2464502C (en) | 2010-11-23 |
| MX250472B (es) | 2007-10-17 |
| ATE408401T1 (de) | 2008-10-15 |
| PL368186A1 (en) | 2005-03-21 |
| JP2005536555A (ja) | 2005-12-02 |
| US20050197434A9 (en) | 2005-09-08 |
| AU2003266232A1 (en) | 2004-03-19 |
| DE10239999A1 (de) | 2004-03-04 |
| ES2314275T3 (es) | 2009-03-16 |
| SI1432409T1 (sl) | 2009-02-28 |
| BR0306143A (pt) | 2004-10-19 |
| US7175857B2 (en) | 2007-02-13 |
| PL206233B1 (pl) | 2010-07-30 |
| BRPI0306143B1 (pt) | 2016-03-08 |
| EP1432409A1 (de) | 2004-06-30 |
| DE50310506D1 (de) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL161145A0 (en) | Granulate or powder for producing coating or binding agents for medicaments | |
| MXPA02010382A (es) | Agente recubrimiento y aglutinacion para composiciones farmaceuticas con estabilidad mejorada en almacenamiento. | |
| IL140771A0 (en) | Coating and excipient agent for oral or dermal dosage forms | |
| EP0868910A3 (de) | Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen | |
| MXPA03007887A (es) | Metodo para obtener microparticulas que contienen inhibidor de h(+), k(+)-atp-asa. | |
| IL162082A0 (en) | Melt extrusion consisting of salts of active ingredients | |
| CA2535013A1 (en) | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents | |
| CA2470656A1 (en) | Corticotropin releasing factor 2 receptor agonists | |
| AU8770301A (en) | Process for the preparation of granules of methionine | |
| AU2002348829A1 (en) | Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| YU92103A (sh) | Granulirani preparati gaboksadola | |
| AU2003224107A1 (en) | Soluble composition containing sporopollenin and the use thereof | |
| TW200503687A (en) | Water-soluble isoflavon composition, manufacture method and usage thereof | |
| AU2002314972A1 (en) | Compressible guaifenesin compositions and method for producing them | |
| SI1699434T1 (sl) | Postopek za pripravo zdravila | |
| RU2002116760A (ru) | Способ производства гранулированных кормов для рыб | |
| AU2002332760A1 (en) | Compositions and methods relating to ovary specific genes and proteins | |
| JP2001192330A5 (enExample) | ||
| UA69746C2 (en) | A method for producing hydroxo apatite | |
| DE60311013D1 (de) | Synergistische leberschützende zusammensetzung und verfahren dazu | |
| ATE534371T1 (de) | Pharmazeutische zubereitungen und verfahren zu deren herstellung |